Echeverria-Garces G, Ramos-Medina M, Gonzalez A, Vargas R, Cabrera-Andrade A, Armendariz-Castillo I
Heliyon. 2024; 10(17):e37488.
PMID: 39296198
PMC: 11409134.
DOI: 10.1016/j.heliyon.2024.e37488.
Mavridou D, Psatha K, Aivaliotis M
J Pers Med. 2024; 14(8).
PMID: 39202022
PMC: 11355716.
DOI: 10.3390/jpm14080831.
Fukumoto K, Kanatani S, Jaremko G, West Z, Li Y, Takamatsu K
JCI Insight. 2024; 9(14).
PMID: 39133649
PMC: 11383588.
DOI: 10.1172/jci.insight.175751.
Boileve A, Smolenschi C, Lambert A, Boige V, Tarabay A, Valery M
World J Gastrointest Oncol. 2024; 16(7):2902-2914.
PMID: 39072173
PMC: 11271790.
DOI: 10.4251/wjgo.v16.i7.2902.
Pham T, Tsunoyama T
Cancers (Basel). 2024; 16(13).
PMID: 39001371
PMC: 11240416.
DOI: 10.3390/cancers16132308.
Current status of precision oncology in adult glioblastoma.
Weller J, Potthoff A, Zeyen T, Schaub C, Duffy C, Schneider M
Mol Oncol. 2024; 18(12):2927-2950.
PMID: 38899374
PMC: 11619805.
DOI: 10.1002/1878-0261.13678.
Gastric cancer actionable genomic alterations across diverse populations worldwide and pharmacogenomics strategies based on precision oncology.
Echeverria-Garces G, Ramos-Medina M, Vargas R, Cabrera-Andrade A, Altamirano-Colina A, Freire M
Front Pharmacol. 2024; 15:1373007.
PMID: 38756376
PMC: 11096557.
DOI: 10.3389/fphar.2024.1373007.
NCT/DKFZ MASTER handbook of interpreting whole-genome, transcriptome, and methylome data for precision oncology.
Mock A, Teleanu M, Kreutzfeldt S, Heilig C, Hullein J, Mohrmann L
NPJ Precis Oncol. 2023; 7(1):109.
PMID: 37884744
PMC: 10603123.
DOI: 10.1038/s41698-023-00458-w.
Cancer metastasis under the magnifying glass of epigenetics and epitranscriptomics.
Janin M, Davalos V, Esteller M
Cancer Metastasis Rev. 2023; 42(4):1071-1112.
PMID: 37369946
PMC: 10713773.
DOI: 10.1007/s10555-023-10120-3.
Usefulness and real-world outcomes of next generation sequencing testing in patients with cancer: an observational study on the impact of selection based on clinical judgement.
Colomer R, Miranda J, Romero-Laorden N, Hornedo J, Gonzalez-Cortijo L, Mouron S
EClinicalMedicine. 2023; 60:102029.
PMID: 37304496
PMC: 10248077.
DOI: 10.1016/j.eclinm.2023.102029.
New Insights into the Impact of Human Papillomavirus on Oral Cancer in Young Patients: Proteomic Approach Reveals a Novel Role for S100A8.
Miranda-Galvis M, Carneiro Soares C, Carnielli C, Ramalho Buttura J, Sales de Sa R, Kaminagakura E
Cells. 2023; 12(9).
PMID: 37174723
PMC: 10177374.
DOI: 10.3390/cells12091323.
Receptor-ligand pair typing and prognostic risk model of response or resistance to immune checkpoint inhibitors in lung adenocarcinoma.
Mao S, Zeng L, Yang Y, Liu Z, Zhang L
Front Oncol. 2023; 13:1170942.
PMID: 37152010
PMC: 10154538.
DOI: 10.3389/fonc.2023.1170942.
Comprehensive genomic profiling: Does timing matter?.
Thapa B, Ahmed G, Szabo A, Kamgar M, Kilari D, Mehdi M
Front Oncol. 2023; 13:1025367.
PMID: 36865796
PMC: 9971445.
DOI: 10.3389/fonc.2023.1025367.
Popular deep learning algorithms for disease prediction: a review.
Yu Z, Wang K, Wan Z, Xie S, Lv Z
Cluster Comput. 2022; 26(2):1231-1251.
PMID: 36120180
PMC: 9469816.
DOI: 10.1007/s10586-022-03707-y.
Comparing Survival Outcomes for Advanced Cancer Patients Who Received Complex Genomic Profiling Using a Synthetic Control Arm.
OHaire S, Degeling K, Franchini F, Tran B, Luen S, Gaff C
Target Oncol. 2022; 17(5):539-548.
PMID: 36063280
PMC: 9512745.
DOI: 10.1007/s11523-022-00910-0.
Tissue is Still the Issue for Precision Oncology: A Novel Web-Based Platform for Lesion Selection and Biopsy Specimen Acquisition.
Subbiah V
J Immunother Precis Oncol. 2022; 4(4):176-177.
PMID: 35665021
PMC: 9138476.
DOI: 10.36401/JIPO-21-X5.
Special Considerations for Tympanoplasty Type I in the Oncological Pediatric Population: A Case-Control Study.
Richard C, Baker E, Wood J
Front Surg. 2022; 9:844810.
PMID: 35350139
PMC: 8957792.
DOI: 10.3389/fsurg.2022.844810.
Dynamic Cancer Cell Heterogeneity: Diagnostic and Therapeutic Implications.
Jacquemin V, Antoine M, Dom G, Detours V, Maenhaut C, Dumont J
Cancers (Basel). 2022; 14(2).
PMID: 35053446
PMC: 8773841.
DOI: 10.3390/cancers14020280.
An Overview of Intracranial Ependymomas in Adults.
Lombardi G, Della Puppa A, Pizzi M, Cerretti G, Bonaudo C, Gardiman M
Cancers (Basel). 2021; 13(23).
PMID: 34885237
PMC: 8656831.
DOI: 10.3390/cancers13236128.
Integrative Metabolomics Reveals Deep Tissue and Systemic Metabolic Remodeling in Glioblastoma.
Gilard V, Ferey J, Marguet F, Fontanilles M, Ducatez F, Pilon C
Cancers (Basel). 2021; 13(20).
PMID: 34680306
PMC: 8534284.
DOI: 10.3390/cancers13205157.
